Cardiac Fibrosis – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... for Cardiac Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiac Fibrosis. Cardiac Fibrosis - Pipeline Review, Half Year ...
|
read more...
|
$2,000.00
|
Male Sexual Dysfunction – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... therapeutic development for Male Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Male Sexual Dysfunction. Male Sexual Dysfunction ...
|
read more...
|
$2,000.00
|
|
|
$4,450.00
|
Metastatic Adenocarcinoma of The Pancreas – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... provides information on the therapeutic development for Metastatic Adenocarcinoma of The Pancreas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ...
|
read more...
|
$2,000.00
|
Essential Tremor – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... for Essential Tremor, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Essential Tremor. Essential Tremor - Pipeline Review, Half Year ...
|
read more...
|
$2,000.00
|
Cancer Pain Global Clinical Trials Review, H1, 2013
4/30/2013 | published by: GlobalData
... information and data relating to the clinical trials on Cancer Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...
|
read more...
|
$2,500.00
|
Xerosis (Dry Skin) – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... therapeutic development for Xerosis (Dry Skin), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Xerosis (Dry Skin). Xerosis (Dry Skin) ...
|
read more...
|
$2,000.00
|
|
|
$2,000.00
|
Influenza A And B Infections – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... provides information on the therapeutic development for Influenza A And B Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ...
|
read more...
|
$2,000.00
|
Arrhythmias – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Arrhythmias. Arrhythmias - Pipeline Review, Half Year is built using data and ...
|
read more...
|
$2,000.00
|
Soft Tissue Sarcoma – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... therapeutic development for Soft Tissue Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Soft Tissue Sarcoma. Soft Tissue Sarcoma ...
|
read more...
|
$2,000.00
|
|
|
$4,450.00
|
Acute Spinal Cord Injury – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... on the therapeutic development for Acute Spinal Cord Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Spinal Cord ...
|
read more...
|
$2,000.00
|
Global Eye Care Surgical Market 2012-2016
4/30/2013 | published by: Infiniti Research Limited
... this market growth is the increase in prevalence of eye disorders. The Global Eye Care Surgical market has also been witnessing the trend of an increase in mergers and acquisitions. However, the lack of awareness ...
|
read more...
|
$2,000.00
|
|
|
$3,500.00
|
Mental Health & Substance Abuse Services
4/29/2013 | published by: First Research, Inc.
... include CRC Health and The Betty Ford Center in the US, the Centre for Addiction and Mental Health in Canada, and the Crossroads Centre in Antigua. Globally, resources for mental health services vary by region. ...
|
read more...
|
$129.00
|
2013 Analysis of the PT and APTT Point-of-Care Testing Market: US, Germany, Spain,-Physician Offices, Emergency Rooms, Operating Suites, ICIs/CUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
4/29/2013 | published by: Venture Planning Group
... landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market. Rationale The growing economic pressures on ...
|
read more...
|
$4,500.00
|
Global Deep Brain Stimulator Market 2012-2016
4/26/2013 | published by: Infiniti Research Limited
... this market growth is the rapidly increasing awareness about deep brain stimulation devices in the US. The Global Deep Brain Stimulator market has also been witnessing the emergence of less invasive and non-invasive treatments. However, ...
|
read more...
|
$2,000.00
|
|
|
$1,020.00
|
|
|
$1,020.00
|
Optometrists in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ...
|
read more...
|
$1,020.00
|
Chiropractors in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ...
|
read more...
|
$1,020.00
|
|
|
$1,020.00
|
|
|
$1,020.00
|
|
|
$5,621.25
|